共 105 条
[1]
Gupta RK(2012)Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis Lancet 380 1250-8
[2]
Jordan MR(2011)Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa J Acquir Immune Defic Syndr 58 23-31
[3]
Sultan BJ(2010)Impact of drug stock-outs on death and retention to care among HIV-infected patients on combination antiretroviral therapy in Abidjan Cote d’Ivoire PLoS One 5 e13414-9
[4]
Hill A(2008)Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy JAMA 300 530-73
[5]
Davis DH(2005)Genetic variability of CYP2B6 in populations of African and Asian origin: allele frequencies, novel functional variants, and possible implications for anti-HIV therapy with efavirenz Pharmacogenet Genomics 15 861-1202
[6]
Gregson J(2008)Changes in prevalence and incidence of HIV-1, HIV-2 and dual infections in urban areas of Bissau, Guinea-Bissau: is HIV-2 disappearing? AIDS 22 1195-22
[7]
Sigaloff KC(1993)The epidemiology of HIV infection in a rural area of Guinea-Bissau AIDS 7 1119-8
[8]
Hamers RL(1993)HIV-2 infection in Bissau, West Africa, 1987–1989: incidence, prevalences, and routes of transmission J Acquir Immune Defic Syndr 6 941-65
[9]
Wallis CL(2004)Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis Antivir Ther 9 57-84
[10]
Kityo C(2013)HIV-1 genetic diversity and drug resistance among Senegalese patients in the public health system J Clin Microbiol 51 578-33